Eiger Biopharmaceuticals, Inc. (EIGR) Stockholder News: Lead Plaintiff Deadline is Fast Approaching; Contact Robbins LLP for More Information
12 déc. 2022 17h06 HE
|
Robbins LLP
SAN DIEGO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...
Eiger Biopharmaceuticals, Inc. (EIGR) Equity Notice: Contact Robbins LLP if You Incurred Significant Damages From Your Investment in Eiger Biopharmaceuticals, Inc.
28 nov. 2022 17h00 HE
|
Robbins LLP
SAN DIEGO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...
Eiger Biopharmaceutials, Inc. (EIGR) Class Action Notice: Contact Robbins LLP For Information if Eiger Biopharmaceutials, Inc. Harmed Your Financial Interests
22 nov. 2022 13h01 HE
|
Robbins LLP
SAN DIEGO, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...